CLINICAL_TRIALS
trial_result
· 2024-02-07
Clinical Trial Update: Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA) [Phase 3]
Summary
Phase 3 trial update for otilimab (GSK3196165) in rheumatoid arthritis shows termination with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Arthritis, Rheumatoid | Phase 3 | Status: TERMINATED | Results posted: 2024-02-07